Morgan Stanley
NVNO

Morgan Stanley’s enVVeno Medical NVNO Stock Holding History

Morgan Stanley’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$770 Sell
76
-6
-7% -$66 ﹤0.01% 7499
2025
Q4 		$922 Sell
82
-24
-23% -$466 ﹤0.01% 7387
2025
Q3 		$3.37K Sell
106
-2,046
-95% -$209K ﹤0.01% 7186
2025
Q2 		$301K Buy
2,152
+267
+14% +$31.6K ﹤0.01% 5688
2025
Q1 		$173K Sell
1,885
-1,742
-48% -$194K ﹤0.01% 5791
2024
Q4 		$383K Sell
3,627
-205
-5% -$22.9K ﹤0.01% 5532
2024
Q3 		$451K Buy
3,832
+1,121
+41% +$206K ﹤0.01% 5452
2024
Q2 		$498K Sell
2,711
-76
-3% -$13.3K ﹤0.01% 5294
2024
Q1 		$531K Sell
2,787
-673
-19% -$121K ﹤0.01% 5284
2023
Q4 		$622K Buy
3,460
+2,222
+179% +$354K ﹤0.01% 5531
2023
Q3 		$233K Buy
1,238
+181
+17% +$30.2K ﹤0.01% 5511
2023
Q2 		$114K Buy
1,057
+231
+28% +$30K ﹤0.01% 5891
2023
Q1 		$135K Sell
826
-43
-5% -$8.04K ﹤0.01% 5885
2022
Q4 		$155K Sell
869
-53
-6% -$10.8K ﹤0.01% 5772
2022
Q3 		$203K Buy
922
+114
+14% +$24.3K ﹤0.01% 5721
2022
Q2 		$107K Sell
808
-219
-21% -$34K ﹤0.01% 6235
2022
Q1 		$230K Sell
1,027
-594
-37% -$115K ﹤0.01% 5844
2021
Q4 		$374K Sell
1,621
-3,280
-67% -$924K ﹤0.01% 5719
2021
Q3 		$1.78M Buy
+4,901
New +$1.27M ﹤0.01% 4661
2019
Q1 		– Hold
0
– – – 6667
2018
Q4 		– Hold
0
– – – 6679

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's NVNO Position: Q1 2026 in Review

Morgan Stanley reduced its enVVeno Medical (NVNO) stake by 7.3% in Q1 2026, selling an estimated $66 and leaving 76 shares worth $770. The position accounts for ﹤0.01% of the portfolio, ranked #7499.

Morgan Stanley first reported a position in NVNO in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.78M in Q3 2021. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Morgan Stanley held 76 shares of enVVeno Medical worth $770 as of Q1 2026.
  • Morgan Stanley sold 6 enVVeno Medical shares in Q1 2026, an estimated $66.
  • enVVeno Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7499 holding.
  • Morgan Stanley first reported a position in enVVeno Medical in Q3 2021 and has held it in 19 quarters since.
  • Morgan Stanley's enVVeno Medical position peaked at $1.78M in Q3 2021.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.